Related Experiment Video
Updated: May 29, 2025

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
Unusually high incidence of pneumonia in Navarre, Spain, 2023-2024
Camino Trobajo-Sanmartín1, María Eugenia Portillo2, Ana Navascués3
1Instituto de Salud Pública de Navarra - IdiSNA, Pamplona, Spain; CIBER Epidemiología y Salud Pública, Madrid, Spain.
Objective:
To assess the pneumonia incidence in Navarre, Spain, in the 2023-2024 season.
Methods:
Using electronic medical records, we evaluated the incidence of clinical pneumonia, positive pneumococcal antigen cases and Mycoplasma pneumoniae positive PCR cases by age groups from 2017-2018 to 2023-2024 season.
Results:
Compared to the average of the 2017-2018 and 2018-2019 seasons, in the 2023-2024 season, pneumonia incidence rate increased by 73% overall and multiplied by 4.43 in the age group of 5-14 years. The rate of confirmed pneumococcal pneumonia increased by 63%, and that of M. pneumoniae multiplied by 19.
Conclusion:
Pneumonia incidence was unusually high in all ages in the 2023-2024 season and was related to upsurges in pneumococcal and Mycoplasma diseases.
More Related Videos
03:53Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses
Published on: November 10, 2023
12:21A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness
Published on: September 28, 2022
Related Concept Videos
Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia II: Pathophysiology
Pneumonia III: Complications and Assessment
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Acute Respiratory Failure-III